mTOR Pathway Biomarkers in Upper Tract Urothelial Carcinoma

SUO 2013 - Evaluation of the Prognostic Significance of Altered Mammalian Target of Rapamycin (MTOR) Pathway Biomarkers in Upper Tract Urothelial Carcinoma

Click HERE to read session highlights from the meeting, reported by the Fox Chase Cancer Center team.